MentionFox
Home › Executive changes › Agenus Inc
Leadership changes · AGEN · SEC Form 8-K, Item 5.02

Leadership changes at Agenus Inc (2026)

Before you join, sell to or invest in Agenus Inc

MentionFox check on Agenus Inc: no red flags found in 4 sources; 1 item to note (checked 15 November 2026). mentionfox.com/c/executive-changes/agenus

  • Note: Layoff plan disclosed Dec 2024 (filing)

New since last check: Layoff plan disclosed Dec 2024 (filing, first seen 14 November 2026).

Check Agenus Inc before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Agenus Inc?

Who joined and who left Agenus Inc (AGEN)? 1 appointment and 1 departure reported from 2026-01-14 to 2026-08-11, each cited to the company's own filing.

Austin Charette's departure as Principal Accounting Officer of Agenus Inc was reported, effective May 29, 2026; the filing names no successor. As of November 15, 2026, Agenus Inc has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from January 14, 2026 to August 11, 2026, naming 1 appointment and 1 departure (Form 8-K, May 15, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Eventide Asset Management, LLC also filed stake reports on 11 other companies ↓

Sell to companies like Agenus Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-08-11
  • · In / out: Out · Person: Austin Charette · Role: Principal Accounting Officer · Effective: 2026-05-29 · 8-K, 2026-05-15
  • · In / out: In · Person: Garo Armen · Role: Chief Financial Officer · Effective: 2026-01-08 · 8-K, 2026-01-14
Changes3
In (appointed)1
Out (departing)1
Latest filing2026-08-11

Agenus Inc reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-14 to 2026-08-11. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Agenus Inc files it.

Layoffs on record: 1 filing or notice, latest 2024-12-05 (layoff filings and notices).

Also on the record for Agenus Inc

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G, by Eventide Asset Management, LLC5.4% of the class5%+ stakesSource
July 27, 2026Stake report, Schedule 13G, by BlackRock, Inc.6% of the class5%+ stakesSource
July 20, 2026Stake report, Schedule 13G, by RA Capital Management, L.P.9.9% of the class5%+ stakesSource
July 17, 2026Stake report, Schedule 13G, by Raymond Debbane9.99% of the class5%+ stakesSource
March 26, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
January 23, 2026Stake report, Schedule 13D, by ZYNEXT VENTURES USA LLC5.9% of the class5%+ stakesSource
October 30, 2025Stake report, Schedule 13G/A, by The Vanguard Group8.06% of the class5%+ stakesSource
July 29, 2025Stake report, Schedule 13G/A, by The Vanguard Group9.23% of the class5%+ stakesSource
July 16, 2025Stake report, Schedule 13G/A, by BlackRock, Inc.1.8% of the class5%+ stakesSource

Selling to them or working with them? See who runs Agenus Inc now and the warning signs.

Free to see. No signup.

Keep reading

More on Agenus Inc and the records around it.

Agenus Inc elsewhere on the record

Companies that share a holder

Want the whole picture on Agenus Inc?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Agenus Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Agenus Inc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-08-11Reportednot named in the filing8-K, 2026-08-11
2026-05-15OutPrincipal Accounting Officer2026-05-298-K, 2026-05-15
2026-01-14InChief Financial Officer2026-01-088-K, 2026-01-14

Why did they leave? What the filings say

Agenus Inc's filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.

Who leads Agenus Inc, as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Agenus Inc?

New leaders reset buying decisions — get the Full Report on Agenus Inc: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Agenus Inc

Hiring for a seat like this?

Find people with the same kind of experience as the Principal Accounting Officer at Agenus Inc, with the record behind each one.

Find candidates like Principal Accounting Officer at Agenus Inc

Every change, in the filing's words

Filed 2026-08-11 · 8-K

Reported

Mr. Marcucci was also appointed to serve as a member of the Board's Corporate Governance and Nominating Committee.

Also stated in this filing

  • On August 5, 2026, the board of directors (the "Board") of Agenus Inc., a Delaware corporation (the "Company"), increased the size of the Board from six (6) to seven (7) directors and appointed Marco Tullio Marcucci to fill the resulting vacancy as a Class II director, to serve until the Company's 2029 annual meeting of stockholders and until his successor is duly elected and qualified, effective immediately.
  • Following Mr. Marcucci's appointment, the Board consists of seven (7) directors, including Brian Corvese and Timothy R. Wright, serving as Class I directors; Garo Armen, Jennifer Buell and Marco Tullio Marcucci, serving as Class II directors; and Susan Hirsch and Thomas Harrison, serving as Class III directors.
  • Mr. Marcucci, age 55, is an attorney based in Rome, Italy.
  • Since 2003, he has practiced at Studio Legale Pecora Marcucci, where he advises individuals and companies on commercial and civil law, administrative and tax litigation, wealth management, capital markets investments, venture capital activities, and domestic and cross-border agreements.
  • He previously served as in-house legal counsel at H3G S.p.A. in Rome and held earlier legal roles involving corporate law, competition law and transnational joint ventures.
  • Mr. Marcucci has been admitted to the Bar Association of Rome since 2002 and to the Special Bar Association of the Supreme Court and High Courts since 2018.
Filed 2026-05-15 · 8-K

Departing: Austin Charette, Principal Accounting Officer, effective 2026-05-29

On May 12, 2026, Austin Charette, Senior Director, Financial Reporting and Compliance and Principal Accounting Officer of Agenus Inc. (the "Company"), informed the Company he will be resigning effective May 29, 2026.
Filed 2026-01-14 · 8-K

Appointed: Garo Armen, Chief Financial Officer, effective 2026-01-08

Effective January 8, 2026, Agenus Inc.'s (the "Company") Board of Directors appointed Dr. Garo Armen, the Company's current Chairman and Chief Executive Officer to serve as the Company's interim Chief Financial Officer ("CFO") and Principal Financial Officer.

Also stated in this filing

  • Dr. Armen, age 72, co-founded the Company in 1994.
  • Under his leadership, Agenus has been advancing breakthrough scientific technologies and immunotherapeutic products.
  • In addition, Dr. Armen oversaw the successful restructuring of the biopharmaceutical company Elan Corporation, plc, where he served as Chairman of the Board of Directors.
  • Dr. Armen began his research career at Brookhaven National Laboratory subsequent to which he made a transition to Wall Street, as an analyst and investment banker at EF Hutton and then at Dean Witter Reynolds (now Morgan Stanley).
  • Dr. Armen received his PhD in physical chemistry from the City University of New York.
  • There were no new arrangements or modifications to existing arrangements entered into with Dr. Armen in connection with his designation as the Company's interim CFO and Principal Financial Officer.
  • Dr. Armen continues to receive his base salary and any potential bonus payments in Agenus stock rather than cash.
  • Mr. Charette, age 37, joined the Company in August 2017 and has served as Senior Director, Financial Reporting and Compliance since January 2026 where he is responsible for the Company's external reporting, technical accounting, internal controls and implementation of new accounting standards.

Tools for this story

Each opens in a new tab, filled in for Agenus Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/agenus
Last updated 2026-11-15
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Agenus Inc executive departure 2026. MentionFox, 2026-11-15. https://mentionfox.com/executive-changes/agenus